Stay updated on FB825 Safety & Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the FB825 Safety & Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the FB825 Safety & Efficacy in Atopic Dermatitis Clinical Trial page
- CheckyesterdayChange DetectedThe page footer revision marker was updated from v3.5.0 to v3.5.3, reflecting a minor technical/version change without altering the displayed ClinicalTrials.gov study information.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. This appears to be a software/version change rather than a change to study content.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision: v3.4.3 has been added and Revision: v3.4.2 has been removed.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1; no visible changes to study content or functionality are indicated.SummaryDifference0.1%

- Check80 days agoChange DetectedA minor site-version update was applied (Revision: v3.4.1) replacing the previous v3.4.0. This change does not affect study details or user actions, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check87 days agoChange DetectedShow glossary was added to the page, and several metadata items were updated: Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. The previous labels and data—Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4—were removed or replaced.SummaryDifference0.2%

Stay in the know with updates to FB825 Safety & Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FB825 Safety & Efficacy in Atopic Dermatitis Clinical Trial page.